A new frontier for medical device trust and patient safety

Tern plc

As clinical environments become increasingly digital and interconnected, medical devices no longer operate in isolation. They link into hospital networks, share data across platforms, interface with cloud services and increasingly fall under regulatory scrutiny. That means the device manufacturers and healthcare providers face new challenges, including how to establish trust, how to manage devices through their lifecycle, and how to ensure compliance with evolving standards. Device Authority’s KeyScaler platform presents itself as a technology to address exactly these challenges in the realm of the Internet of Medical Things (IoMT).

At a fundamental level the platform begins with device trust. Each device must be registered, authenticated and clearly identified before it transmits patient data or interfaces with clinical systems. Once that trust anchor is in place, KeyScaler automates credential issuance and lifecycle management so that as devices are deployed, maintained, updated or retired the identity and certificate infrastructure is managed at scale.

Connected devices are generating streams of sensitive patient information, system telemetry and operational metrics. Encryption, secure updates and policy‑driven access become mandatory. The KeyScaler platform emphasises end‑to‑end encryption, including the ability to manage data both at rest and in transit, and to enforce policies on how and when keys can be used.

Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Talking Medicines targets a growing data need around GLP-1 treatment journeys

Talking Medicines is using GLP-1 discontinuation conversations to show how DrugVoice can help pharmaceutical companies track changing patient needs across the treatment journey.

Device Authority adopts usage-based pricing to support KeyScaler expansion

Device Authority has moved KeyScaler to usage-based pricing, aiming to reduce licensing friction and support broader adoption of its machine identity security platform.

Talking Medicines targets growing demand for GLP-1 patient intelligence

Talking Medicines is using GLP-1 patient conversations to show how behavioural data can help pharmaceutical companies understand changing treatment expectations and engagement.

Talking Medicines builds its AI strategy around specialist life sciences intelligence

Talking Medicines is positioning specialist healthcare intelligence as the core layer that gives agentic AI useful context in life sciences.

Device Authority targets cyber resilience opportunity at TechWorks Summit 2026

Device Authority will focus on continuous IoT and OT compliance, AI and quantum risk at TechWorks Summit 2026 as it strengthens its position in connected-device security.

Talking Medicines builds a more defensible AI model for life sciences

Talking Medicines is combining proprietary healthcare intelligence, AI agents and orchestration to build a more specialised AI platform for life sciences.

Search